Natalizumab in secondary progressive multiple sclerosis

被引：3
|
作者：
Edan, Gilles [1 ]
机构：
[1] CHU Pontchaillou, INSERM, CIC1414, F-35033 Rennes, France
来源：
LANCET NEUROLOGY | 2018年 / 17卷 / 05期
关键词：
MS;
D O I：
10.1016/S1474-4422(18)30108-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [31] Natalizumab in multiple sclerosis
    Rajda Cecilia
    Bencsik Krisztina
    Vecsei Laszlo
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2008, 61 (5-6): : 204 - 208
  • [32] Natalizumab for multiple sclerosis
    Ransohoff, Richard M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (25): : 2622 - 2629
  • [33] Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis
    Harding-Forrester, Sam
    Roos, Izanne
    Sharmin, Sifat
    Diouf, Ibrahima
    Malpas, Charles
    Nguyen, Ai-Lan
    Moradi, Nahid
    Horakova, Dana
    Havrdova, Eva Kubala
    Patti, Francesco
    Ayuso, Guillermo Izquierdo
    Madueno, Sara Eichau
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Onofrj, Marco
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Weinstock-Guttman, Bianca
    Amato, Maria Pia
    Grammond, Pierre
    Gerlach, Oliver
    Ozakbas, Serkan
    Sola, Patrizia
    Ferraro, Diana
    Butzkueven, Helmut
    Lechner-Scott, Jeannette
    Boz, Cavit
    Alroughani, Raed
    Van Pesch, Vincent
    Cartechini, Elisabetta
    Terzi, Murat
    Maimone, Davide
    Ramo-Tello, Cristina
    Spitaleri, Daniele Litterio A.
    Kappos, Ludwig
    Yamout, Bassem
    Sa, Maria Jose
    Slee, Mark
    Morgado, Yolanda Blanco
    Bergamaschi, Roberto
    Butler, Ernest
    Iuliano, Gerardo
    Granella, Franco
    Sidhom, Youssef
    Gouider, Riadh
    Ampapa, Radek
    Van Wijmeersch, Bart
    Karabudak, Rana
    Prevost, Julie
    NEUROLOGY, 2021, 96 (15)
  • [34] Cognition in secondary progressive multiple sclerosis(SPMS)
    Doshi, A.
    De Angelis, F.
    Muhlert, N.
    Prados, F.
    Stutters, J.
    Macmanus, D.
    Wheeler-Kingshott, C. A. Gandini
    Cicarelli, O.
    Barkhof, F.
    Chataway, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 562 - 563
  • [35] Siponimod: A Review in Secondary Progressive Multiple Sclerosis
    Lesley J. Scott
    CNS Drugs, 2020, 34 : 1191 - 1200
  • [36] Management of Secondary-Progressive Multiple Sclerosis
    Gavin Giovannoni
    CNS Drugs, 2004, 18 : 653 - 669
  • [37] Prospects of siponimod in secondary progressive multiple sclerosis
    McGinley, Marisa
    Fox, Robert J.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [38] Therapeutic approaches to secondary progressive multiple sclerosis
    Lublin, FD
    MULTIPLE SCLEROSIS, 2002, 8 (01): : 88 - 90
  • [39] Immunopathology of secondary-progressive multiple sclerosis
    Prineas, JW
    Kwon, EE
    Cho, ES
    Sharer, LR
    Barnett, MH
    Oleszak, EL
    Hoffman, B
    Morgan, BP
    ANNALS OF NEUROLOGY, 2001, 50 (05) : 646 - 657
  • [40] Interferon beta for secondary progressive multiple sclerosis
    La Mantia, Loredana
    Vacchi, Laura
    Di Pietrantonj, Carlo
    Ebers, George
    Rovaris, Marco
    Fredrikson, Sten
    Filippini, Graziella
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01):
12345